Related Experiment Videos
Disseminated intravascular coagulation
Insights
Disseminated intravascular coagulation (DIC) is a critical condition often linked to underlying diseases. Prompt diagnosis and individualized treatment are vital for managing hemorrhage or thrombosis risks and improving patient outcomes.
Area of Science:
- Hematology
- Pathophysiology
- Critical Care Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a complex syndrome, frequently a complication of other serious conditions like infection or malignancy.
- It involves widespread activation of coagulation, leading to thrombin generation, fibrin deposition in microcirculation, and consumption of platelets and clotting factors.
- DIC can result in life-threatening hemorrhage or thrombosis, affecting vital organs, or may present subtly as abnormal coagulation tests.
Purpose of the Study:
- To elucidate the pathophysiology of disseminated intravascular coagulation (DIC).
- To emphasize the importance of integrating clinical observation with laboratory data for accurate diagnosis.
- To highlight the need for individualized therapeutic approaches in managing DIC.
Main Methods:
- Review of the pathophysiology of disseminated intravascular coagulation (DIC).
- Analysis of diagnostic challenges and controversies in treatment.
- Emphasis on clinical and laboratory data integration for diagnosis.
Main Results:
- The central mechanism of DIC is thrombin generation, leading to microvascular thrombosis.
- Consumption of coagulation factors and platelets, coupled with enhanced fibrinolysis, can cause hemorrhage.
- Early recognition and appropriate management are crucial for survival.
Conclusions:
- Understanding DIC pathophysiology is key to diagnosis and management.
- Individualized therapy, balancing risks and benefits, is essential.
- Prompt recognition and supportive care for acute DIC can be lifesaving.
Abstract:
Known variously as disseminated intravascular coagulation, defibrination consumption coagulopathy or, more simply, as defibrination, disseminated intravascular coagulation is a serious epiphenomenon that occurs most often as a complicating factor of an underlying disease process. Although frequently triggered by underlying disease such as infection or tumor, if not recognized and treated appropriately, disseminated intravascular coagulation alone may lead to the patient's death as a result of hemorrhage or thrombosis, or both, of vital organs. Frequently, it may only manifest itself as an abnormality of coagulation tests, causing no immediate problem for the patient, and potentially normalizing when the inciting cause is appropriately managed. The central process that marks disseminated intravascular coagulation is the generation of thrombin in the circulating blood by means of the activation of the coagulation mechanism, leading to the conversion of fibrinogen to fibrin, which, in turn, may lead to thrombosis mainly of the microcirculation. Because platelets and coagulation factors are consumed and fibrinolysis is enhanced during the coagulation process, hemorrhage may also ensue. Although disseminated intravascular coagulation is frequently encountered in medical and obstetric patients, the difficulty in diagnosis and controversy regarding optimal therapy are frustrating for both patient and physician. By understanding the pathophysiology of disseminated intravascular coagulation and combining clinical observation and laboratory data, one can arrive at the appropriate diagnosis. Therapy must be individualized, and assessment of the benefit versus risk ratio of intervention must be made. Early recognition of acute and life-threatening disseminated intravascular coagulation can be lifesaving with appropriate supportive measures.